Related Experiment Videos
Interleukin-13 and -4 induce death of activated microglia
Myung-Soon Yang1, Eun Jung Park, Seonghyang Sohn
1Department of Pharmacology, Ajou University School of Medicine, Suwon, Korea.
Abstract:
When the brain suffers injury, microglia migrate to the damaged sites and become activated. These activated microglia are not detected several days later and the mechanisms underlying their disappearance are not well characterized. In this study, we demonstrate that interleukin (IL)-13, an anti-inflammatory cytokine, selectively induces cell death of activated microglia in vitro. Cell death was detected 4 days after the coaddition of IL-13 with any one of the microglial activators, lipopolysaccharide (LPS), ganglioside, or thrombin. This cell death occurred in a time-dependent manner. LPS, ganglioside, thrombin, or IL-13 alone did not induce cell death. Among anti-inflammatory cytokines, IL-4 mimicked the effect of IL-13, while TGF-beta did not. Cells treated with IL-13 plus LPS, or IL-13 plus ganglioside, showed the characteristics of apoptosis when analyzed by electron microscopy and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining. Electron micrographs also showed microglia engulfing neighboring dead cells. We propose that IL-13 and IL-4 induce death of activated microglia, and that this process is important for prevention of chronic inflammation that can cause tissue damage.
Insights
Interleukin-13 (IL-13) selectively induces apoptosis in activated microglia, a key immune cell in brain injury. This finding suggests a novel mechanism for clearing these cells and preventing chronic neuroinflammation.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia are immune cells that activate and migrate to sites of brain injury.
- The mechanisms responsible for the clearance of activated microglia post-injury are not well understood.
- Persistent microglial activation can contribute to chronic inflammation and tissue damage.
Purpose of the Study:
- To investigate the mechanisms underlying the disappearance of activated microglia following brain injury.
- To determine the role of interleukin-13 (IL-13) in regulating activated microglia populations.
- To explore the potential of IL-13 as a therapeutic target for neuroinflammatory conditions.
Main Methods:
- In vitro studies using primary microglial cultures.
- Treatment with microglial activators (lipopolysaccharide, ganglioside, thrombin) and anti-inflammatory cytokines (IL-13, IL-4, TGF-beta).
- Assessment of cell death using electron microscopy and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining.
Main Results:
- IL-13 selectively induced cell death in activated microglia, but not in unstimulated cells.
- Cell death occurred in a time-dependent manner following co-administration of IL-13 with microglial activators.
- IL-4 mimicked IL-13's effect, while TGF-beta did not.
- Apoptotic features and microglial phagocytosis of dead cells were observed.
Conclusions:
- IL-13 and IL-4 induce apoptosis in activated microglia.
- This cytokine-mediated microglial cell death is a crucial mechanism for preventing chronic neuroinflammation.
- Targeting this pathway may offer therapeutic benefits for brain injury and related inflammatory diseases.